Insmed (INSM) reported 93.43millioninrevenueforthequarterendedSeptember2024,representingayear−over−yearincreaseof18.21.27 for the same period compares to -1.10ayearago.ThereportedrevenuecomparestotheZacksConsensusEstimateof93.31 million, representing a surprise of +0.12%. The company delivered an EPS surprise of -6.72%, with the consensus EPS estimate being -$1.19.While investors closely watch year-over-year changes in headline numbers -- revenue and earnings -- an ...